Iannetta, M., Landi, D., Cola, G., Malagnino, V., Teti, E., Fraboni, D., . . . Sarmati, L. (2021). T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Mult Scler Relat Disord.
Chicago Style CitationIannetta, Marco, et al. "T-cell Responses to SARS-CoV-2 in Multiple Sclerosis Patients Treated With Ocrelizumab Healed From COVID-19 With Absent or Low Anti-spike Antibody Titers." Mult Scler Relat Disord 2021.
Cita MLAIannetta, Marco, et al. "T-cell Responses to SARS-CoV-2 in Multiple Sclerosis Patients Treated With Ocrelizumab Healed From COVID-19 With Absent or Low Anti-spike Antibody Titers." Mult Scler Relat Disord 2021.
Atenció: Aquestes cites poden no estar 100% correctes.